Long-term outcomes have now been reported to show a clear trend toward improved patient and graft survival.
← all excerpts
Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants.
1
—
—
Long-term outcomes have now been reported to show a clear trend toward improved patient and graft survival.